Metformin decreases hyaluronan synthesis by vascular smooth muscle cells

Metformin is the first-line drug in the treatment of type 2 diabetes worldwide based on its effectiveness and cardiovascular safety. Currently metformin is increasingly used during pregnancy in women with gestational diabetes mellitus, even if the long-term effects of metformin on offspring are not...

Descripción completa

Detalles Bibliográficos
Autores principales: Sainio, Annele, Takabe, Piia, Oikari, Sanna, Salomäki-Myftari, Henriikka, Koulu, Markku, Söderström, Mirva, Pasonen-Seppänen, Sanna, Järveläinen, Hannu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063400/
https://www.ncbi.nlm.nih.gov/pubmed/31672719
http://dx.doi.org/10.1136/jim-2019-001156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063400/
https://www.ncbi.nlm.nih.gov/pubmed/31672719
http://dx.doi.org/10.1136/jim-2019-001156

Ejemplares similares